Aurinia: Q4 Earnings Snapshot

EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $26.9 million in its fourth quarter.

On a per-share basis, the Edmonton, Alberta-based company said it had a loss of 19 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The biotechnology company posted revenue of $45.1 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $43.6 million.

For the year, the company reported that its loss narrowed to $78 million, or 54 cents per share. Revenue was reported as $175.5 million.

Aurinia shares have dropped 11% since the beginning of the year. The stock has climbed roughly 1% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH